<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
    <title><![CDATA[EU/3/16/1653 (Resiquimod) - Galderma RandD]]></title>
    <ttl>1440</ttl>
    <copyright>Copyright: (C) European Commission</copyright>
    <language>en-gb</language>
    <atom:link href="http://ec.europa.eu/health/documents/community-register/html/rss/o1653.rss" rel="self" type="application/rss+xml" />
    <lastBuildDate>Mon, 02 May 2016 12:05:00 +0000</lastBuildDate>
    <link>http://ec.europa.eu/health/documents/community-register/html/o1653.htm</link>
    <description><![CDATA[EU/3/16/1653 (Active substance: Resiquimod) - EU number: EU/3/16/1653 - Marketing authorisation holder: Galderma RandD]]>
    </description>
    <image>
        <title><![CDATA[EU/3/16/1653 (Resiquimod) - Galderma RandD]]></title>
        <url>http://ec.europa.eu/health/documents/community-register/images/logo_en.gif</url>
        <link>http://ec.europa.eu/health/documents/community-register/html/o1653.htm</link>
        <width>144</width>
        <height>100</height>
    </image>
    <item>
        <title>Orphan designation - Commission Decision (2016) 2739 of Mon, 02 May 2016</title>
        <category>New documents</category>
        <guid isPermaLink="true">http://ec.europa.eu/health/documents/community-register/html/o1653.htm#proc134716</guid>
        <link>http://ec.europa.eu/health/documents/community-register/html/o1653.htm#proc134716</link>
        <description><![CDATA[Orphan designation) - Commission Decision (2016) 2739 of Mon, 02 May 2016 - European Medicines Agency (EMA) procedure number: EMA/OD/254/15]]></description>
        <pubDate>Mon, 02 May 2016 12:05:00 +0000</pubDate>
    </item>
    </channel>
</rss>
